Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

YOD1-C160S activates transport. 1 / 1

| 1

➶

reach

"The results showed that the active site mutant of YOD1 (C160S) inhibited the reverse transport of various misfolded proteins, and results showed that the accumulation of RI332 in YOD1 (C160S) cells (without deubiquitination activity) was much higher than that in YOD1 wild-type cells [XREF_BIBR]."

33546413

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...